These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30085402)

  • 1. Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain.
    Brindisi M; Borrelli G; Brogi S; Grillo A; Maramai S; Paolino M; Benedusi M; Pecorelli A; Valacchi G; Di Cesare Mannelli L; Ghelardini C; Allarà M; Ligresti A; Minetti P; Campiani G; di Marzo V; Butini S; Gemma S
    ChemMedChem; 2018 Oct; 13(19):2090-2103. PubMed ID: 30085402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
    Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S
    Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
    Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
    Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Jaiswal S; Gupta G; Ayyannan SR
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH).
    Aghazadeh Tabrizi M; Baraldi PG; Ruggiero E; Saponaro G; Baraldi S; Romagnoli R; Martinelli A; Tuccinardi T
    Eur J Med Chem; 2015 Jun; 97():289-305. PubMed ID: 26002335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Ruggiero E; De Stefano L; Rizzolio F; Di Cesare Mannelli L; Ghelardini C; Chicca A; Lapillo M; Gertsch J; Manera C; Macchia M; Martinelli A; Granchi C; Minutolo F; Tuccinardi T
    J Med Chem; 2018 Feb; 61(3):1340-1354. PubMed ID: 29309142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel propanamides as fatty acid amide hydrolase inhibitors.
    Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
    Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.
    Grim TW; Ghosh S; Hsu KL; Cravatt BF; Kinsey SG; Lichtman AH
    Pharmacol Biochem Behav; 2014 Sep; 124():405-11. PubMed ID: 25058512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.
    Keith JM; Hawryluk N; Apodaca RL; Chambers A; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Rizzolio M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1280-4. PubMed ID: 24513048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
    Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
    J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
    Sunduru N; Svensson M; Cipriano M; Marwaha S; Andersson CD; Svensson R; Fowler CJ; Elofsson M
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):513-521. PubMed ID: 28114819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
    Jaiswal S; Tripathi RKP; Ayyannan SR
    Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S; Di Marzo V
    Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.